Literature DB >> 10049988

Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation.

B Fauroux1, M Boulé, F Lofaso, F Zérah, A Clément, A Harf, D Isabey.   

Abstract

OBJECTIVE: Chest physiotherapy (CPT) is an integral part of the treatment of patients with cystic fibrosis (CF). CPT imposes additional respiratory work that may carry a risk of respiratory muscle fatigue. Inspiratory pressure support ventilation (PSV) is a new mode of ventilatory assistance designed to maintain a constant preset positive airway pressure during spontaneous inspiration with the goal of decreasing the patient's inspiratory work. The aim of our study was 1) to evaluate respiratory muscle fatigue and oxygen desaturation during CPT and 2) to determine whether noninvasive PSV can relieve these potential adverse effects of CPT.
METHODS: Sixteen CF patients in stable condition with a mean age of 13 +/- 4 years participated to the study. For CPT, we used the forced expiratory technique (FET), which consisted of one or more slow active expirations starting near the total lung capacity (TLC) and ending near the residual volume. After each expiration, the child was asked to perform a slow, nonmaximal, diaphragmatic inspiration. After one to four forced breathing cycles, the child was asked to cough and to expectorate. A typical 20-minute CPT session consisted of 10 to 15 FET maneuvers separated by rest periods of 10 to 20 breathing cycles each. During the study, each patient received two CPT sessions in random order on two different days, at the same time of day, with the same physiotherapist. During one of these two sessions, PSV was provided throughout the session (PSV session) via a nasal mask using the pressure support generator ARM25 designed for acute patients (TAEMA, Antony, France). The control session was performed with no nasal mask or PSV. Both CPT sessions were performed without supplemental oxygen. Lung function and maximal inspiratory pressures (PImax) and expiratory pressures (PEmax) were recorded before and after each CPT session.
RESULTS: Mean lung function parameters were comparable before the PSV and the control sessions. Baseline pulse oximetry (SpO2) was significantly correlated with the baseline vital capacity (% predicted) and forced expiratory volume in 1 second (FEV1) (% predicted). PSV was associated with an increase in tidal volume (Vt) from 0.42 +/- 0.01 liters to 1.0 +/- 0.02 liters. Respiratory rate was significantly lower during PSV. SpO2 between the FET maneuvers was significantly higher during PSV as compared with the control session. SpO2 decreases after FET were significantly larger during the control session (nadir: 91.8 +/- 0. 7%) than during the PSV session (93.8 +/- 0.6%). Maximal pressures decreased during the control session (from 71.9 +/- 6.1 to 60.9 +/- 5.3 cmH2O, and from 85.3 +/- 7.9 to 77.5 +/- 4.8 cmH2O, for PImax and PEmax, respectively) and increased during the PSV session (from 71.6 +/- 8.6 to 83.9 +/- 8.7 cmH2O, and from 80.4 +/- 7.8 to 88.0 +/- 7.4 cmH2O, for PImax and PEmax, respectively). The decrease in PEmax was significantly correlated with the severity of bronchial obstruction as evaluated based on baseline FEV1 (% predicted). Forced expiratory flows did not change after either CPT session. The amount of sputum expectorated was similar for the two CPT sessions (5.3 +/- 5.3 g vs 4.6 +/- 4.8 g after the control and PSV session, respectively; NS). Fifteen patients felt less tired after the PSV session. Ten patients reported that expectoration was easier with PSV, whereas 4 did not note any difference; 2 patients did not expectorate. Nine patients expressed a marked and 5 a small preference for PSV, and 2 patients had no preference. The physiotherapists found it easier to perform CPT with PSV in 14 patients and did not perceive any difference in 2 patients. DISCUSSION: Our study in CF children shows that respiratory muscle performance, as evaluated based on various parameters, decreased after CPT and that significant falls in oxygen saturation occurred after the FET maneuvers despite the quiet breathing periods between each FET cycle. These unwanted effects of CPT were

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049988     DOI: 10.1542/peds.103.3.e32

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis.

Authors:  A E Holland; L Denehy; G Ntoumenopoulos; M T Naughton; J W Wilson
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 2.  [Pediatric home ventilation--practical approach].

Authors:  Regina Rath-Wacenovsky
Journal:  Wien Med Wochenschr       Date:  2015-10-28

Review 3.  Non-invasive ventilation for cystic fibrosis.

Authors:  Fidelma Moran; Judy M Bradley; Amanda J Piper
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

Review 4.  Oxygen therapy for cystic fibrosis.

Authors:  Heather E Elphick; George Mallory
Journal:  Cochrane Database Syst Rev       Date:  2013-07-25

5.  Results of active cycle of breathing techniques and conventional physiotherapy in mucociliary clearance in children with cystic fibrosis.

Authors:  A Hristara-Papadopoulou; J Tsanakas
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

6.  Physiological effects of noninvasive positive ventilation during acute moderate hypercapnic respiratory insufficiency in children.

Authors:  Sandrine Essouri; Philippe Durand; Laurent Chevret; Vincent Haas; Claire Perot; Annick Clement; Denis Devictor; Brigitte Fauroux
Journal:  Intensive Care Med       Date:  2008-08-19       Impact factor: 17.440

Review 7.  Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.

Authors:  Louise Warnock; Alison Gates
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

8.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

9.  Mechanical insufflation-exsufflation for airway clearance in adults with cystic fibrosis.

Authors:  Madeline Gaynor; Jamie Wood
Journal:  Respirol Case Rep       Date:  2018-02-28

Review 10.  Active cycle of breathing technique for cystic fibrosis.

Authors:  Naomi A Mckoy; Lisa M Wilson; Ian J Saldanha; Olaide A Odelola; Karen A Robinson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.